Initiation of Section 301 Investigation; Hearing; and Request for Public Comments: Germany's Persistent Underpayment for Innovative Pharmaceutical Products
USTR Section 301 action · Investigation initiation
The United States Trade Representative (U.S. Trade Representative) has initiated an investigation pursuant to the Trade Act of 1974, as amended (Trade Act), with respect to Germany's persistent underpayment for innovative pharmaceutical products. The inter-agency Section 301 Committee is holding a public hearing and seeking public comments in connection with this investigation.
Frequently asked questions
What does Federal Register notice 2026-12671 — Initiation of Section 301 Investigation; Hearing; and Request for Public Comments: Germany's Persistent Underpayment… — require?
“The United States Trade Representative (U.S. Trade Representative) has initiated an investigation pursuant to the Trade Act of 1974, as amended (Trade Act), with respect to Germany's persistent underpayment for innovative pharmaceutical products. The inter-agency Section 301 Committee is holding a public hearing and seeking public comments in connection with this investigation.” Importers affected by this action should treat the full Federal Register text as authoritative before making entry or pricing decisions.
Who issued notice 2026-12671 and when does it take effect?
The Office of the United States Trade Representative issued notice 2026-12671. It was published on 24 Jun 2026; the notice states no single effective date, so the Federal Register text governs timing. Classified as a notice under the Germany matter.
Where can I verify notice 2026-12671?
The authoritative text is the Federal Register document itself, reachable via the Source link on this page. ExportSonar mirrors metadata only (snapshot fetched 18 Oct 2026, 01:46 UTC); when the two differ, the Federal Register record wins.